| P50 | author | Raymond L. Woosley | Q7298947 |
| P2093 | author name string | Oates JA | |
| | Nies AS | |
| | Carr K | |
| P2860 | cites work | Acetylation pattern of different sulphonamides in rapid and slow isoniazid inactivators | Q71330049 |
| | The fluorometric measurement of 4,4'-diaminodiphenyl sulfone and its acetylated derivatives in plasma and urine | Q71477095 |
| | A new analytical procedure for dapsone. Application to blood-level and urinary-excretion studies in normal men | Q72051148 |
| | Depression of parahydroxylation of diphenylhydantoin by antituberculosis chemotherapy | Q72877695 |
| | INVESTIGATION OF THE GENETIC CONTROL OF SULFADIAZINE AND ISONIAZID METABOLISM IN THE RABBIT | Q76614484 |
| | HUMAN ACETYLATION POLYMORPHISM | Q76849232 |
| | Genetic control of isoniazid metabolism in man | Q79227074 |
| | Hydralazine elimination in man | Q93748537 |
| | Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype | Q28237156 |
| | Simultaneous quantification of procainamide and N-acetylprocainamide with high-performance liquid chromatography | Q28335494 |
| | An improved and simplified method of detecting the acetylator phenotype | Q28365202 |
| | Polymorphic acetylation of procainamide in man | Q40325311 |
| | Acetylation polymorphism of sulfapyridine in patients with ulcerative colitis and Crohn's disease | Q40347145 |
| | The discrimination of phenotypes for rate of disappearance of isonicotinoyl hydrazide from serum | Q40473561 |
| | The haemolytic effects of diaphenylsulfone (DDS) in normal subjects and in those with glucose-6-phosphate-dehydrogenase deficiency | Q40656977 |
| | Peripheral neuritis due to isoniazid. | Q42031537 |
| | Absorption, metabolism and excretion of di(rho-aminophenyl) sulphone (dapsone) and di(rho-aminophenyl) sulphoxide in man | Q42279775 |
| | Isoniazid acetylatlon rate and development of antinuclear antibodies upon isoniazid treatment | Q43446032 |
| | The polymorphic acetylation of dapsone in man | Q43471156 |
| | GENETICS OF ISONIAZID METABOLISM IN CAUCASIAN, NEGRO, AND JAPANESE POPULATIONS. | Q46975424 |
| | Relationship of acetyl transferase activity to antinuclear antibodies and toxic symptoms in hypertensive patients treated with hydralazine | Q47772528 |
| | Genetical and geographic studies on isoniazid inactivation | Q47810911 |
| | Enzymatic N-acetylation of carcinogenic aromatic amines by liver cytosol of species displaying different organ susceptibilities | Q53600585 |
| | THE INFLUENCE OF ACETYLATOR PHENOTYPE ON THE EFFECTS OF TREATING DEPRESSION WITH PHENELZINE. | Q64916448 |
| | Antiarrhythmic potency of N-acetylprocainamide | Q66918767 |
| | Comparison of the acetylation of procainamide and sulfadimidine in man | Q67826140 |
| | Relation of hydralazine plasma concentration to dosage and hypotensive action | Q70374161 |
| | A chromatographic-fluorometric procedure for the determination of nanogram quantities of antileprotic sulfones | Q70529876 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dapsone | Q422226 |
| | high-performance liquid chromatography | Q381233 |
| | monoacetyldapsone | Q27273637 |
| P304 | page(s) | 421-427 | |
| P577 | publication date | 1978-11-01 | |
| P1433 | published in | British Journal of Clinical Pharmacology | Q176044 |
| P1476 | title | Simultaneous analysis of dapsone and monoacetyldapsone employing high performance liquid chromatography: a rapid method for determination of acetylator phenotype | |
| P478 | volume | 6 | |